Medline ® Abstract for Reference 36
of 'Adjuvant therapy for resected stage III (node-positive) colon cancer'
Eto T, Kotaka M, Manaka D, et al. An international phase III randomized, non-inferiority trial comparing 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy for colon cancer: Compliance and safety of the phase III Japanese ACHIEVE trial (abstract). J Clin Oncol 34, 2016 (suppl; abstr 3550). Abstract available at http://meetinglibrary.asco.org/record/123781/abstract (Accessed on June 27, 2017).
no abstract available